Symmetrical and asymmetrical growth restriction in preterm-born children

Inger Bocca-Tjeertes1, Arend Bos, Jorien Kerstjens

  • 1Departments of Pediatrics, Division of Neonatology, and.

Pediatrics
|February 4, 2014
PubMed

Insights

Both symmetric (SGR) and asymmetric (AGR) growth restriction in preterm infants lead to similar, poorer weight and height gains compared to non-growth restricted (NGR) infants. Developmental delay is more likely in growth-restricted preterms.

Area of Science:

  • Neonatal development
  • Pediatric growth studies
  • Perinatal medicine

Background:

  • Premature infants often experience growth restriction, impacting long-term development.
  • Distinguishing between symmetric (SGR) and asymmetric (AGR) growth restriction is crucial for understanding varied outcomes.
  • Previous research indicates potential differences in developmental trajectories based on growth restriction patterns.

Purpose of the Study:

  • To compare the growth and developmental outcomes of preterm infants with symmetric (proportionate) and asymmetric (disproportionate) growth restriction.
  • To assess the influence of SGR and AGR on growth from birth to 4 years of age.
  • To determine the association between growth restriction types and developmental delay at 4 years.

Main Methods:

  • A community-based cohort study included 810 preterm infants (86 SGR, 61 AGR, 663 NGR) born in 2002-2003.
  • SGR defined by birth weight <16th percentile and HC z-score not exceeding birth weight z-score by >1 SD.
  • AGR defined by HC z-score exceeding birth weight z-score by >1 SD (brain sparing proxy); developmental delay assessed using Ages and Stages Questionnaire at 4 years.

Main Results:

  • Longitudinal weight and height gains were similar between SGR and AGR groups, and less than NGR infants.
  • At 4 years, weight z-scores were -1.1 (SGR), -0.7 (AGR), vs. -0.3 (NGR); height z-scores were -0.8 (SGR), -0.5 (AGR), vs. -0.2 (NGR).
  • SGR infants showed greater head circumference (HC) gain, but by 1 year, HC z-scores were -0.2 (SGR) vs. 0.2 (AGR) and 0.1 (NGR); developmental delay odds ratios were 2.5 (SGR) and 2.1 (AGR).

Conclusions:

  • Weight and height catch-up were similar for AGR and SGR preterm infants, but lagged behind NGR infants.
  • Symmetric growth-restricted infants achieved catch-up in head circumference.
  • Developmental delay risk was elevated in both SGR and AGR preterm infants, irrespective of initial head circumference.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967